ONCT

Oncternal Therapeutics, Inc. Common Stock
ONCT

Overview Fund Trends Analyst Outlook Journalist POV
Delisted

ONCT was delisted on the 2nd of December, 2024.

Back to rankings

38 hedge funds and large institutions have $4.58M invested in Oncternal Therapeutics, Inc. Common Stock in 2023 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 6 increasing their positions, 8 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

more capital invested

Capital invested by funds: $ → $

less funds holding

Funds holding: →

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less first-time investments, than exits

New positions opened: | Existing positions closed:

Holders
38
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$219K
2
+$119K
3
+$47.2K
4
Citadel Advisors
Citadel Advisors
Florida
+$29.1K
5
TSS
Two Sigma Securities
New York
+$20.1K

Top Sellers

1
-$144K
2
-$138K
3
-$102K
4
Corient Private Wealth
Corient Private Wealth
Florida
-$27.5K
5
Envestnet Asset Management
Envestnet Asset Management
Illinois
-$16.2K
Name Holding Trade Value Shares
Change 		Change in
Stake
26
$10.8K
27
$10.5K
28
$4.75K
29
$3.44K
30
$2.68K
31
$2.66K
32
$1.95K
33
$1.07K
34
$236
35
$161
36
$161
37
$19
38
$11
39
$4
40
$4
41
$1
42
–
43
–
44
–
45
–
46
–
47
–
48
–
49
–
50
–
1
2
3